shengmai injection

Shengmai Injection is an approved traditional Chinese medicine injectable developed and marketed by Shanghai Hutchison Pharmaceuticals for cardiovascular and shock-related indications in China. It is a multi-herb formulation derived from the classical Shengmai San prescription and contains extracts of red ginseng, ophiopogon, and schisandra. Public product information describes its intended effects as tonifying qi, nourishing yin, restoring pulse, and treating patients with patterns corresponding to palpitations, dyspnea, cold extremities, diaphoresis, threatened pulse collapse, myocardial infarction, cardiogenic shock, and infectious shock. Mechanistically, it is not a single-target drug; instead, it is presented as a complex botanical injectable with reported pharmacologic effects on cardiac function, coronary blood flow, myocardial metabolism, microcirculation, arrhythmia, inflammation, and immune modulation.

Brand names

生脉注射液Shengmai Injection

Other names

Shengmai Injection生脉注射液